Weekly Rundown: Key Catalysts for Small-Cap Stocks (August 4–8)

From recent disclosures to corporate shifts, we’ve highlighted the top small-cap catalysts to watch. Here’s your weekly preview (August 4–8).

Companies with Catalysts This Week:

COCP

●Oral presentation of CDI-988 at the Military Health System Research Symposium (MHSRS), Aug 4–7 in Kissimmee, FL.

●Presentation by President/Co-CEO Dr. Sam Lee on Aug 4, highlighting Phase 1 results for CDI-988, a pan-viral protease inhibitor developed for norovirus.

●CDI-988 also selected for oral presentation at the 9th International Calicivirus Conference (Sept 7–11 in Banff, Alberta).

VGZ

●Participating in the Diggers & Dealers Mining Forum, Aug 4–6 in Kalgoorlie, Western Australia.

NRSN

●Live webcast with CEO Alon Ben-Noon and actor Aaron Lazar, now an ALS advocate, on Aug 4 at 2:00 PM ET.

WTI

●Founder/CEO Tracy Krohn to ring the NYSE closing bell on Aug 4 at 3:55 PM ET, celebrating the company’s 20th NYSE anniversary.

IMDX

●Two favorable oral abstracts to be presented at the World Transplant Congress, Aug 2–6 in San Francisco.

BTCS

●Fireside chat with CEO Charles Allen and Water Tower Research on Aug 6 at 1:00 PM ET.

ALZN

●Poster presentation at MHSRS, Aug 4–7, in Orlando,FL. CEO Stephan Jackman highlights innovation for military health.

OXBR

●Presenting at Rare Evo 2025, a blockchain convention held Aug 6–10 at Caesars Palace, Las Vegas.

DARE

● Webinar on Aug 6, unveiling DARE to PLAY™, a sildenafil cream formulation for female arousal disorder.

OSRH

●Virtual investor event on Aug 6 at 8:00 AM ET with updates on strategy, R&D pipeline, and subsidiary performance.

ELDN

● Hosting a conference call and webcast on Aug 6 at 4:30 PM ET to discuss updated Phase 1b kidney transplant data presented at the World Transplant Congress.

MOBX

● Participating in the Leidos Supplier Innovation & Tech Symposium, Aug 7 at the Gaylord National Resort, DC. Focus on mmWave, radar, and IC tech.

ADAP

●Entered an asset sale agreement with US WorldMeds for multiple cell therapies.

●The deal closing deadline is Aug 4, 2025.

SND

● Declared a $0.10 special dividend, payable Aug 14, with record date of Aug 4.

AMBP

● Declared a $0.10 quarterly interim dividend, payable Aug 19 to shareholders of record on Aug 7.

ZEO

● Special meeting for Heliogen merger vote scheduled for Aug 8 at 9:00 AM ET via live webcast.

SSY

●Special meeting reconvenes Aug 4 at 10:00 AM ET to vote on merger with Regional Health.

RSLS

● Special meeting resumes Aug 7 at 11:30 AM ET to vote on:

○Asset sale to Ninjour Health

○Charter amendments for proposed merger with Vyome Therapeutics

AEMD

● Research with UCSF accepted for poster presentation at Keystone Symposium, Aug 10–13 (event announced this week).

FAAS

● Signed termsheet with High West Capital Partners for up to $3M non-recourse debt, expected to close within the first or second week of August.

● Proceeds will fund Bitcoin treasury launch as part of a $100M reserve strategy.

SILO

● Acquired software and domains (r2crypto.com, etc.) under asset purchase agreement; domain transfer expected by Aug 15.

SCNI

●Received Golden Power clearance from Italian government for planned Pincell acquisition.

●Awaiting decision on €12M grant application from Poland under FENG program, expected by early August.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.